Additional file 2 of ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors

Additional file 2 : Figure S1. The prognostic value of ITGA5 expression in non-gastrointestinal cancers. (A-D) Correlation between ITGA5 expression and prognosis of lung cancer and breast cancer in Kaplan-Meier Plotter; (E-F) Correlation between ITGA5 expression and prognosis of ovarian cancer in PrognoScan. OS, overall survival; DFS, disease free survival. Figure S2. The full-length, original blots for CD163 (A), ITGA5 (B), GATA3 (C) and STAT6 (D) in 6 paired gastric cancer tissues (T) and adjacent normal tissues (N). (the order of samples from left to right are: marker, N1, T1, N2, T2, N3, T3, marker, N4, T4, N5, T5, N6, T6, marker).

附加文件2：图S1。整合素α5（ITGA5）表达对非胃肠道肿瘤的预后价值。（A-D）基于Kaplan-Meier Plotter数据库的肺癌与乳腺癌中ITGA5表达与预后的相关性分析；（E-F）基于PrognoScan数据库的卵巢癌中ITGA5表达与预后的相关性分析。总生存期（overall survival，OS）、无病生存期（disease-free survival，DFS）。
图S2：6对胃癌组织（T）及配对癌旁正常组织（N）中CD163（A）、ITGA5（B）、GATA结合蛋白3（GATA3，C）与信号转导与转录激活因子6（STAT6，D）的全长原始免疫印迹条带。（样本从左至右依次为：分子量Marker、N1、T1、N2、T2、N3、T3、分子量Marker、N4、T4、N5、T5、N6、T6、分子量Marker）